Discovery and Development of Anti-HBV Agents and Their Resistance

Hepatitis B virus (HBV) infection is a prime cause of liver diseases such as hepatitis, cirrhosis and hepatocellular carcinoma. The current drugs clinically available are nucleot(s)ide analogues that inhibit viral reverse transcriptase activity. Most drugs of this class are reported to have viral re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyun-Hwan, Kim, Nam Doo, Seong, Baik-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257723/
https://www.ncbi.nlm.nih.gov/pubmed/20802402
http://dx.doi.org/10.3390/molecules15095878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257723/
https://www.ncbi.nlm.nih.gov/pubmed/20802402
http://dx.doi.org/10.3390/molecules15095878

Ejemplares similares